...
首页> 外文期刊>Journal of neuroendocrinology >Intracellular calcium increase and somatodendritic vasopressin release by vasopressin receptor agonists in the rat supraoptic nucleus: involvement of multiple intracellular transduction signals.
【24h】

Intracellular calcium increase and somatodendritic vasopressin release by vasopressin receptor agonists in the rat supraoptic nucleus: involvement of multiple intracellular transduction signals.

机译:大鼠视上核中血管加压素受体激动剂的细胞内钙增加和树突状血管加压素释放:涉及多个细胞内转导信号。

获取原文
获取原文并翻译 | 示例
           

摘要

Vasopressin neurones of the supraoptic nucleus are autoregulated by vasopressin released from their soma and dendrites. Vasopressin binds to specific autoreceptors to trigger an influx of Ca(2+), and this response involves both phospholipase C (PLC) and adenylate cyclase (AC) pathways that, in the periphery, are activated by V(1) (V(1a) and V(1b))- and V(2)-type receptors. To investigate the pathways involved in the [Ca(2+)](i) response, [Ca(2+)](i) measurements were made on freshly dissociated neurones using Fura-2 microspectrofluorimetry, and vasopressin release was measured from isolated supraoptic nuclei. The [Ca(2+)](i) increase and vasopressin release induced by the V(1a) agonist were strongly inhibited by a PLC blocker, an IP(3) receptor antagonist, and a PKC blocker. An AC inhibitor did not affect the V(1a) response, while PKA inhibitors significantly reduced the V(1a)-induced [Ca(2+)](i) and release responses. The [Ca(2+)](i) increase and vasopressin release elicited by the V(2) agonist were attenuated not only by AC pathway blockers, but also by PLC inhibitors. Surprisingly, the V(1b) agonist showed no [Ca(2+)](i) or vasopressin release response. In conclusion, the V(1a) agonist activates both PLC and AC pathway, confirming the functional expression of a V(1a) vasopressin receptor on vasopressin neurones. The V(2) agonist activation of both PLC and AC pathways could result from an action on the PLC-linked unknown receptor, and/or the AC-linked dual angiotensin II-vasopressin receptor.
机译:视上核的血管加压素神经元由其体和树突中释放的加压素自动调节。加压素与特定的自体受体结合以触发Ca(2+)涌入,并且该反应涉及磷脂酶C(PLC)和腺苷酸环化酶(AC)途径,这些途径在外围被V(1)(V(1a )和V(1b))和V(2)型受体。若要调查参与[Ca(2 +)](i)反应的途径,使用Fura-2显微荧光法对新鲜离解的神经元进行了[Ca(2 +)](i)测量,并从孤立的超视光中测量了加压素释放核。 [Ca(2 +)](i)的增加和V(1a)激动剂诱导的加压素释放被PLC阻滞剂,IP(3)受体拮抗剂和PKC阻滞剂强烈抑制。 AC抑制剂不影响V(1a)反应,而PKA抑制剂则显着降低V(1a)诱导的[Ca(2 +)](i)和释放反应。 [Ca(2 +)](i)的增加和V(2)激动剂引起的加压素释放不仅被AC通路阻滞剂减弱,而且被PLC抑制剂减弱。出乎意料的是,V(1b)激动剂没有显示[Ca(2 +)](i)或加压素释放反应。总之,V(1a)激动剂激活PLC和AC途径,从而确认V(1a)血管加压素受体在神经加压素上的功能性表达。 PLC和AC途径的V(2)激动剂激活可能是由对PLC连接的未知受体和/或AC连接的双重血管紧张素II-加压素受体的作用引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号